查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1772214

美國急性腦室引流市場規模、佔有率、趨勢分析報告（按應用、患者類型、細分市場預測），2025-2030 年

U.S. Acute External Ventricular Drain Market Size, Share & Trends Analysis Report By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage), By Patient Type (Pediatric, Adult), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年美國急性腦室引流市場規模將達到 8,650 萬美元，2025 年至 2030 年的複合年成長率為 7.9%。

預計這一成長將受到非創傷性水腦症患病率上升、對微創或非侵入性神經外科手術的需求增加以及技術改進設備的採用率上升的推動。由於事故、運動傷害和中風發生率的增加，對外部腦室引流（EVD）手術的需求正在穩步成長。

隨著老齡化社會的擴大，中風和動脈瘤等疾病的發病率不斷上升，進一步增加了對腦血管疾病 (EVD) 手術的需求。例如，根據世界銀行集團的數據，2018 年美國65 歲及以上人口總數為 4,998 萬，預計到 2023 年將成長至 5,838 萬。醫療基礎設施的進步以及配備處理急性神經系統疾病的急診和創傷中心的增加也促進了市場的成長。

EVD 系統的技術創新，例如改進的導管設計、抗菌塗層和整合監測功能，改善了患者的治療效果並降低了感染風險，使這些設備對醫療保健提供者更具吸引力。越來越多的醫院和診所採用這些先進的 EVD 系統，以提高治療效率並最大限度地減少併發症。此外，人們對微創神經外科的日益重視也推動了 EVD 的需求，因為 EVD 可以以比傳統手術方法創傷更小的方式處理腦脊髓液排放。

推動市場擴張的另一個因素是美國醫療支出的不斷成長以及神經外科手術的優惠報銷政策。根據美國醫療保險和醫療補助服務中心的數據，預計到2023年，美國的醫療支出將增加7.5%，達到4.9兆美元，相當於每人14,570美元。腦血管病變（EVD）植入及相關治療的保險覆蓋範圍將擴大患者的可及性，並鼓勵醫院投資這些設備。此外，醫生越來越意識到在重症加護環境中早期有效腦脊髓液管理的益處，這也推動了腦脊髓液的採用率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國急性腦室引流市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 分析美國急性腦室引流市場的工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • 美國急性腦室引流市場：管道分析

第4章。美國急性腦室引流市場：應用估計與趨勢分析

  • 按用途細分儀表板
  • 美國急性腦室引流市場：應用趨勢分析
  • 美國急性腦室引流市場規模及應用趨勢分析（2018-2030）
  • 創傷性腦損傷
  • 蜘蛛網膜下腔出血
  • 腦出血
  • 其他非創傷性水腦症

第5章美國急性腦室引流市場：依病患類型估計與趨勢分析

  • 按患者類型細分儀表板
  • 美國急性腦室引流市場：依病患類型進行的變化分析
  • 2018-2030年美國急性腦室引流市場規模及趨勢分析（依病患類型）
  • 孩子們
  • 成人

第6章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • Key company heat map analysis, 2024
  • 公司簡介
    • Medtronic
    • Integra LifeSciences Corporation
    • Anuncia Medical, Inc.
    • Natus
    • Fuji Systems
    • B Braun/Aesculap
    • Boston Scientific
    • Abbott
Product Code: GVR-4-68040-650-6

Market Size & Trends:

The U.S. acute external ventricular drain market size was valued at USD 86.5 million in 2024 and is projected to grow at a CAGR of 7.9% from 2025 to 2030. The growth is expected to be driven by the rising prevalence of non-traumatic hydrocephalus, increased demand for minimal or noninvasive neurosurgeries, and the rising adoption of technologically improved devices. With the growing incidence of accidents, sports injuries, and strokes, the demand for external ventricular drain (EVD) procedures is rising steadily.

As the aging population expands, the prevalence of conditions like strokes and aneurysms rises, further boosting the need for EVD procedures. For instance, according to the World Bank Group, the total population aged 65 and above in the U.S. was 49.98 million in 2018, increasing to 58.38 million in 2023. In addition, advancements in healthcare infrastructure and the rising number of emergency and trauma centers equipped to handle acute neurological cases contribute to market growth.

Technological innovations in EVD systems, such as improved catheter designs, antimicrobial coatings, and integrated monitoring capabilities, enhance patient outcomes and reduce infection risks, making these devices more appealing to healthcare providers. Hospitals and clinics increasingly adopt these advanced EVD systems to improve treatment efficiency and minimize complications. Moreover, the growing emphasis on minimally invasive neurosurgical techniques supports the demand for EVDs, as they offer a less invasive solution for managing CSF drainage than traditional surgical methods.

Another factor fueling market expansion is the rising healthcare expenditure in the U.S., coupled with favorable reimbursement policies for neurological procedures. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased by 7.5% in 2023, reaching USD 4.9 trillion, which amounts to USD 14,570 per person. Insurance coverage for EVD placements and related treatments ensures broader patient access, encouraging hospitals to invest in these devices. Furthermore, increased physician awareness about the benefits of early and effective CSF management in critical care settings drives higher adoption rates.

U.S. Acute External Ventricular Drain Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. acute external ventricular drain market report based on application, and patient type.

  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Traumatic Brain Injury
  • Subarachnoid hemorrhage
  • Intracerebral hemorrhage
  • Other Non-Traumatic Hydrocephalus conditions
  • Patient Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Pediatric
  • Adult

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Patient Type
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Patient type outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Acute External Ventricular Drain Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Acute External Ventricular Drain Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Acute External Ventricular Drain Market: Pipeline Analysis

Chapter 4. U.S. Acute External Ventricular Drain Market: Application Estimates & Trend Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. U.S. Acute External Ventricular Drain Market: Application Movement Analysis
  • 4.3. U.S. Acute External Ventricular Drain Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Traumatic Brain Injury
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 4.5. Subarachnoid Hemorrhage
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Intracerebral Hemorrhage
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other Non-Traumatic Hydrocephalus Conditions
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Acute External Ventricular Drain Market: Patient Type Estimates & Trend Analysis

  • 5.1. Patient Type Segment Dashboard
  • 5.2. U.S. Acute External Ventricular Drain Market: Patient Type Movement Analysis
  • 5.3. U.S. Acute External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
  • 5.4. Pediatric
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Adult
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company heat map analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Medtronic
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Integra LifeSciences Corporation
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Anuncia Medical, Inc.
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Natus
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Fuji Systems
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. B Braun/Aesculap
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Boston Scientific
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Abbott
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. acute external ventricular drain market, by application, 2018-2030 (USD Million)
  • Table 3 U.S. acute external ventricular drain market, by patient type, 2018-2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. acute external ventricular drain market: market outlook
  • Fig. 10 U.S. acute external ventricular drain competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. acute external ventricular drain market driver impact
  • Fig. 16 U.S. acute external ventricular drain market restraint impact
  • Fig. 17 U.S. acute external ventricular drain market strategic initiatives analysis
  • Fig. 18 U.S. acute external ventricular drain market: Application movement analysis
  • Fig. 19 U.S. acute external ventricular drain market: Application outlook and key takeaways
  • Fig. 20 Traumatic brain injury market estimates and forecasts, 2018 - 2030
  • Fig. 21 Subarachnoid hemorrhage market estimates and forecasts, 2018 - 2030
  • Fig. 22 Intracerebral hemorrhage market estimates and forecasts, 2018 - 2030
  • Fig. 23 Other non-traumatic hydrocephalus conditions market estimates and forecasts, 2018 - 2030
  • Fig. 24 U.S. acute external ventricular drain market: Patient Type movement analysis
  • Fig. 25 U.S. acute external ventricular drain market: Patient Type outlook and key takeaways
  • Fig. 26 Pediatric market estimates and forecasts, 2018 - 2030
  • Fig. 27 Adult market estimates and forecasts, 2018 - 2030